Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers.
- DOI
- 10.1038/s41420-021-00635-5
- Published
- 2021 Sep 27
- Container
- Cell death discovery
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41420-021-00635-5,
title = {Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers.},
author = {Loo SY and Syn NL and Koh AP and Teng JC and Deivasigamani A and Tan TZ and Thike AA and Vali S and Kapoor S and Wang X and Wang JW and Tan PH and Yip GW and Sethi G and Huang RY and Hui KM and Wang L and Goh BC and Kumar AP},
year = {2021},
journal = {Cell death discovery},
doi = {10.1038/s41420-021-00635-5},
url = {https://doi.org/10.1038/s41420-021-00635-5}
}RIS
TY - JOUR TI - Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers. AU - Loo SY AU - Syn NL AU - Koh AP AU - Teng JC AU - Deivasigamani A AU - Tan TZ AU - Thike AA AU - Vali S AU - Kapoor S AU - Wang X AU - Wang JW AU - Tan PH AU - Yip GW AU - Sethi G AU - Huang RY AU - Hui KM AU - Wang L AU - Goh BC AU - Kumar AP PY - 2021 JO - Cell death discovery DO - 10.1038/s41420-021-00635-5 UR - https://doi.org/10.1038/s41420-021-00635-5 ER -
APA
SY, L., NL, S., AP, K., JC, T., A, D., TZ, T., AA, T., S, V., S, K., X, W., JW, W., PH, T., GW, Y., G, S., RY, H., KM, H., L, W., BC, G., & AP, K. (2021). Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers.. Cell death discovery. https://doi.org/10.1038/s41420-021-00635-5
Source records
- pubmed · retrieved 2026-09-26T22:10:49.690Z